## DVN: Devon Energy Corporation - XLE: Energy

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.8% in mid entry zone (3.0-6.0%), top 6% cross-sectional ranking. Short-term MRS_5 (4.1%) confirms momentum alignment. Strong momentum (+7.6% 5-day acceleration). Outperforming sector by 2.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($35.93)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Roth/MKM and UBS Positive on Devon Energy (DVN) After Bakken Capital Efficiency and Cost-Cutting Programs**
- Source: Finviz | 20260102T105000 | Bullish | Relevance: 100%
- Roth/MKM and UBS have both issued positive reports on Devon Energy (DVN), citing strong capital efficiency in its Bakken operations and effective cost-cutting programs. Roth/MKM reaffirmed its Buy rating with a $42 price target based on a bullish 2026 output model, while UBS upgraded DVN to Buy due to an improving oil outlook and an expected $1 billion debt reduction, along with significant cost savings anticipated by year-end. These factors are expected to bolster confidence in the company's financial performance and future capital expenditures.

**2. Roth/MKM and UBS positive on Devon Energy (DVN) after Bakken capital efficiency and cost-cutting programs**
- Source: MSN | 20260102T161421 | Bullish | Relevance: 100%
- This article highlights how Roth/MKM and UBS have maintained positive ratings on Devon Energy (DVN). The positive outlooks are attributed to Devon's successful implementation of capital efficiency and cost-cutting programs in the Bakken region. These initiatives are expected to improve the company's financial performance.

**3. Roth/MKM and UBS Positive on Devon Energy (DVN) After Bakken Capital Efficiency and Cost-Cutting Programs**
- Source: Insider Monkey | 20260102T105000 | Bullish | Relevance: 100%
- Roth/MKM reaffirmed its Buy rating on Devon Energy (DVN) with a $42 price target, citing optimistic production predictions for 2026 and consistent capital expenditure expectations. UBS upgraded DVN to Buy due to an improving oil outlook for late 2026 and an anticipated $1 billion debt reduction, expecting capital allocation improvements and cost-cutting to reduce 2027 capital expenditures significantly below Street estimates. Devon Energy is also exploring hydrogen as part of its energy transition.

**4. VIRGINIA RETIREMENT SYSTEMS ET Al Invests $3.42 Million in Devon Energy Corporation $DVN**
- Source: MarketBeat | 20260102T103658 | Somewhat-Bullish | Relevance: 100%
- Virginia Retirement Systems Et Al recently invested $3.42 million in Devon Energy Corporation, acquiring 97,500 shares in Q3. Institutional investors hold approximately 69.7% of DVN, with several firms increasing their stakes. Analyst ratings are generally positive ("Moderate Buy") with a consensus price target of $44.86, while the stock currently trades around $36.66 and offers a 2.6% annual dividend yield.

**5. Devon Energy Stock: Energy Cycles, Shareholder Cash, and a Market Caught Between Yield and Volatilit**
- Source: AD HOC NEWS | 20260101T050748 | Neutral | Relevance: 100%
- Devon Energy (DVN) stock has seen recent declines linked to crude price volatility, prompting investors to question if it's a value opportunity or a warning signal for future energy prices. Despite the short-term pullback, the company's strong cash return profile from its U.S. shale operations, particularly in the Delaware Basin, continues to attract income-oriented investors. Wall Street analysts maintain a cautious "Buy" stance, recognizing the upside potential tempered by concerns about future commodity prices and the variability of dividends.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-31 | Roth Capital | $42 | $42 | 0% |
| 2025-12-17 | Citigroup | $44 | $43 | +2% |
| 2025-12-12 | UBS | $46 | $40 | +15% |
| 2025-12-12 | Mizuho | $43 | $40 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-31 | Roth Capital | reit | Buy |
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-12 | UBS | up | Buy |
| 2025-12-12 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.2%)
- Blackrock Inc.: 9.6% (+4.5%)
- State Street Corpora: 5.6% (-4.9%)
- Geode Capital Manage: 3.0% (+2.1%)
- Victory Capital Mana: 1.9% (+5.0%)

### Key Risks

1. Valuation stretched: PEG 14.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +7%) could attract flows.
- Momentum building: MRS_10 improving +7.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 14.90 signals overvaluation risk, limited margin of safety. Forward P/E 9.1x stretched relative to 3% growth. Quality metrics strong (margin 16%). Revenue declining -10% YoY, concerning. Analyst sentiment positive (4 raises, avg +7%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.0B |
| Beta | 0.67 |
| 52W Range | $25.89 - $38.88 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 14.90 |
| Forward P/E | 9.1 |
| Current P/E | 9.3 |
| YoY Growth | 2.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.8% to 4.8% (+7.6% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 93rd percentile. MRS_5 at 4.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.80% (CS: 94) | Strong |
| RSI_14 | 59.8 | Neutral |
| MACD Histogram | -0.00 | Bearish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.070x | Above |
| vs SMA200 | 1.121x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $37.87
- **Stop Loss:** $35.93 (5.1% risk)
- **Target:** $40.78 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 742
- **Position Value:** $28,099.54
- **Portfolio %:** 28.10%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-17 (Est: $0.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.94 | $1.04 | +10.6% |
| 2025Q2 | $0.86 | $0.84 | -2.8% |
| 2025Q1 | $1.23 | $1.21 | -1.5% |
| 2024Q4 | $1.00 | $1.16 | +15.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*